Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa
Paris, June 20, 2024.
Sanofi and Biovac, a Cape Town, South Africa-based biopharmaceutical company, announce today their local manufacturing partnership to produce inactivated polio vaccines (IPV) in Africa. This agreement is designed to enable...
Zur Pressemeldung auf www.sanofi.com